Park West Asset Management LLC bought a new stake in shares of Azenta, Inc. (NASDAQ:AZTA – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 300,000 shares of the company’s stock, valued at approximately $15,000,000.
A number of other large investors also recently modified their holdings of the company. Virtu Financial LLC purchased a new stake in Azenta in the 3rd quarter worth $352,000. Nordea Investment Management AB lifted its stake in Azenta by 5.7% in the 4th quarter. Nordea Investment Management AB now owns 84,804 shares of the company’s stock worth $4,326,000 after purchasing an additional 4,606 shares in the last quarter. Oak Thistle LLC purchased a new stake in Azenta in the 4th quarter worth $927,000. Assenagon Asset Management S.A. purchased a new stake in Azenta in the 4th quarter worth $200,000. Finally, Ballentine Partners LLC lifted its stake in Azenta by 2.0% in the 4th quarter. Ballentine Partners LLC now owns 20,340 shares of the company’s stock worth $1,017,000 after purchasing an additional 404 shares in the last quarter. Hedge funds and other institutional investors own 99.08% of the company’s stock.
Wall Street Analysts Forecast Growth
AZTA has been the topic of several research analyst reports. Stephens reiterated an “overweight” rating and issued a $60.00 price target on shares of Azenta in a research note on Thursday, January 2nd. Evercore ISI upped their target price on shares of Azenta from $50.00 to $52.00 and gave the company an “in-line” rating in a research report on Thursday, February 6th. TD Cowen upgraded shares of Azenta to a “hold” rating in a research report on Thursday, February 27th. Finally, Needham & Company LLC upped their target price on shares of Azenta from $55.00 to $59.00 and gave the company a “buy” rating in a research report on Thursday, February 6th.
Azenta Trading Up 1.1 %
Shares of NASDAQ AZTA opened at $27.02 on Tuesday. The stock has a market capitalization of $1.23 billion, a price-to-earnings ratio of -9.07 and a beta of 1.66. Azenta, Inc. has a 12-month low of $24.06 and a 12-month high of $63.58. The firm’s 50-day moving average price is $34.66 and its 200-day moving average price is $43.11.
Azenta (NASDAQ:AZTA – Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, beating the consensus estimate of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. On average, equities analysts predict that Azenta, Inc. will post 0.53 EPS for the current fiscal year.
About Azenta
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Featured Stories
- Five stocks we like better than Azenta
- What is the S&P/TSX Index?
- Kroger: This Must-Own Staples Stock Thrives in Every Market
- How to Evaluate a Stock Before Buying
- Aerospace and Defense Stocks Take Flight After Strong Earnings
- What is a Stock Market Index and How Do You Use Them?
- Occidental’s Hidden Gem: How OxyChem Could Boost Profits
Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTA – Free Report).
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.